Document is current

Article History

Received: 6 August 2024

Accepted: 26 November 2024

First Online: 5 December 2024

Declarations

:

: The ethics committee of the Beijing Anding Hospital, Capital Medical University, Beijing, China, approved the study design (approval number: 2023292FS-2). Written informed consent will be obtained from all participants before randomization. The trial is registered at the Chinese Clinical Trial Registry (ChiCTR) website (). The trial results will be published in peer-reviewed journals and at conferences. Written, informed consent to participate will be obtained from all participants”.

: Not applicable. No identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The participant information materials and informed consent form are available from the corresponding author on request.

: The authors declare no competing interests.